Obesity – Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026
Obesity Emerging Therapy and TPP Insights Thelansis’s “Obesity Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product profiles (TPPs), trial designs, and KOL insights on key emerging therapies and key drug development opportunities in the indication . Obesity Overview Obesity is a complex, chronic disease characterized by an excessive accumulation of body fat that can impair health. It is a major global health concern with an increasing prevalence driven by a combination of genetic, environmental, social, and psychological factors. From a life science perspective, obesity is not simply a matter of caloric imbalance, but involves intricate hormonal and metabolic dysregulation. Adipose tissue, once considered a passive energy store, is now recognized as a highly active endocrine organ that secretes adipokines, which influence insulin sensitivity, inflammation, and app...